{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T23:31:15Z","timestamp":1777159875574,"version":"3.51.4"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/pas.0000000000000428","type":"journal-article","created":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T17:22:21Z","timestamp":1428081741000},"page":"1148-1155","source":"Crossref","is-referenced-by-count":51,"title":["Atypical Polypoid Adenomyoma of the Uterus"],"prefix":"10.1097","volume":"39","author":[{"given":"Krist\u00fdna","family":"N\u011bmejcov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Laco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"\u0160kapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libor","family":"Stan\u011bk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Zik\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Kleiblov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Dundr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210131","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00000478-198107000-00006","article-title":"Atypical polypoid adenomyomas of the endometrium.","volume":"5","author":"Mazur","year":"1981","journal-title":"Am J Surg Pathol"},{"key":"R2-16-20210131","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2559.1995.tb00288.x","article-title":". Atypical polypoid adenomyomas of the uterus.","volume":"27","author":"Fukunaga","year":"1995","journal-title":"Histopathology"},{"key":"R3-16-20210131","first-page":"101","article-title":"Atypical polypoid adenomyoma mixed with endometrioid carcinoma: a case report.","volume":"34","author":"Nejkovic","year":"2013","journal-title":"Eur J Gynaecol Oncol"},{"key":"R4-16-20210131","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00404-012-2355-x","article-title":"Atypical polypoid adenomyomas progressed to endometrial endometrioid adenocarcinomas.","volume":"286","author":"Zhang","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"R5-16-20210131","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0046-8177(03)00246-6","article-title":". Molecular pathology of atypical polypoid adenomyoma of the uterus.","volume":"34","author":"Ota","year":"2003","journal-title":"Hum Pathol"},{"key":"R6-16-20210131","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.humpath.2013.06.020","article-title":". Frequent beta-catenin gene mutations in atypical polypoid adenomyoma of the uterus.","volume":"45","author":"Takahashi","year":"2014","journal-title":"Hum Pathol"},{"key":"R7-16-20210131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/path.2744","article-title":". The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas.","volume":"222","author":"Kobel","year":"2010","journal-title":"J Pathol"},{"key":"R8-16-20210131","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2559.2011.03907.x","article-title":"Patterns of p53 immunoreactivity in endometrial carcinomas: all or nothing staining is of importance.","volume":"59","author":"McCluggage","year":"2011","journal-title":"Histopathology"},{"key":"R9-16-20210131","first-page":"1049","article-title":"Atypical polypoid adenomyoma of the uterus: an analysis of 17 cases In Chinese.","volume":"92","author":"Chen","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R10-16-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-199601000-00001","article-title":". Atypical polypoid adenomyofibromas (atypical polypoid adenomyomas) of the uterus. A clinicopathologic study of 55 cases.","volume":"20","author":"Longacre","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R11-16-20210131","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ygyno.2012.12.040","article-title":". Clinical management of atypical polypoid adenomyoma of the uterus. A clinicopathological review of 29 cases.","volume":"129","author":"Matsumoto","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R12-16-20210131","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ajcp\/86.2.139","article-title":"Atypical polypoid adenomyoma of the uterus. A report of 27 cases.","volume":"86","author":"Young","year":"1986","journal-title":"Am J Clin Pathol"},{"key":"R13-16-20210131","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2559.2005.02315.x","article-title":"Atypical polypoid adenomyoma: a systematic review of the English literature.","volume":"48","author":"Heatley","year":"2006","journal-title":"Histopathology"},{"key":"R14-16-20210131","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3109\/09513590.2013.777418","article-title":"A multiple perspectives on atypical polypoid adenomyoma of uterus.","volume":"29","author":"Jiang","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"R15-16-20210131","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/path.4185","article-title":"Germline and somatic polymerase epsilon and delta mutations define a new class of hypermutated colorectal and endometrial cancers.","volume":"230","author":"Briggs","year":"2013","journal-title":"J Pathol"},{"key":"R16-16-20210131","doi-asserted-by":"crossref","first-page":"e30801","DOI":"10.1371\/journal.pone.0030801","article-title":". FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features.","volume":"7","author":"Byron","year":"2012","journal-title":"PLoS One"},{"key":"R17-16-20210131","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Kandoth C, Schultz N, Cherniack AD, et al.. Integrated genomic characterization of endometrial carcinoma.","volume":"497","year":"2013","journal-title":"Nature"},{"key":"R18-16-20210131","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1515\/cclm-2013-0162","article-title":". Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium.","volume":"52","author":"Chmelarova","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"R19-16-20210131","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5507\/bp.2013.035","article-title":". Methylation analysis of tumor suppressor genes in endometroid carcinoma of endometrium using MS-MLPA.","volume":"157","author":"Dvorakova","year":"2013","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"R20-16-20210131","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1200\/JCO.2006.06.7173","article-title":"Molecular and pathologic aspects of endometrial carcinogenesis.","volume":"24","author":"Hecht","year":"2006","journal-title":"J Clin Oncol"},{"key":"R21-16-20210131","first-page":"228","article-title":"A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.","volume":"81","author":"Lax","year":"1997","journal-title":"Verh Dtsch Ges Pathol"},{"key":"R22-16-20210131","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/his.12053","article-title":"Molecular pathology of endometrial carcinoma.","volume":"62","author":"Matias-Guiu","year":"2013","journal-title":"Histopathology"},{"key":"R23-16-20210131","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/S0002-9440(10)63732-7","article-title":". Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells.","volume":"164","author":"Saegusa","year":"2004","journal-title":"Am J Pathol"},{"key":"R24-16-20210131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/path.856","article-title":"Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation.","volume":"194","author":"Saegusa","year":"2001","journal-title":"J Pathol"},{"key":"R25-16-20210131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2478\/v10042-009-0014-2","article-title":". Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.","volume":"47","author":"Dobrzycka","year":"2009","journal-title":"Folia Histochem Cytobiol"},{"key":"R26-16-20210131","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1028-4559(08)60102-3","article-title":"Molecular carcinogenesis of endometrial cancer.","volume":"46","author":"Liu","year":"2007","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R27-16-20210131","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1158\/1078-0432.CCR-04-2670","article-title":". BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression.","volume":"11","author":"Feng","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R28-16-20210131","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":". Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers.","volume":"92","author":"Mutter","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R29-16-20210131","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1158\/0008-5472.CAN-08-1154","article-title":". PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma.","volume":"68","author":"Lacey","year":"2008","journal-title":"Cancer Res"},{"key":"R30-16-20210131","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/modpathol.2011.208","article-title":". Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing.","volume":"25","author":"Djordjevic","year":"2012","journal-title":"Mod Pathol"},{"key":"R31-16-20210131","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1158\/0008-5472.CAN-13-0544","article-title":". A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 is highly responsive to mTOR inhibition.","volume":"74","author":"Cheng","year":"2014","journal-title":"Cancer Res"},{"key":"R32-16-20210131","doi-asserted-by":"crossref","first-page":"e95219","DOI":"10.1371\/journal.pone.0095219","article-title":". Activation of the PI3KmTORAKT pathway and survival in solid tumors: systematic review and meta-analysis.","volume":"9","author":"Ocana","year":"2014","journal-title":"PLoS One"},{"key":"R33-16-20210131","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/cncr.10341","article-title":". Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.","volume":"94","author":"Hamid","year":"2002","journal-title":"Cancer"},{"key":"R34-16-20210131","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/01.MP.0000095646.70007.6A","article-title":". Tissue microarray immunohistochemical expression analysis of mismatch repair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrial hyperplasia: relationship with microsatellite instability.","volume":"16","author":"Hardisson","year":"2003","journal-title":"Mod Pathol"},{"key":"R35-16-20210131","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1158\/1078-0432.CCR-09-0506","article-title":". Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia.","volume":"15","author":"Nieminen","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R36-16-20210131","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00004347-200304000-00005","article-title":". Loss of expression of MLH1, MSH2, MSH6, and PTEN related to endometrial cancer in 68 patients with endometrial hyperplasia.","volume":"22","author":"Orbo","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R37-16-20210131","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/hupa.2002.32220","article-title":". Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma.","volume":"33","author":"Peiro","year":"2002","journal-title":"Hum Pathol"},{"key":"R38-16-20210131","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ijc.1206","article-title":". MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer.","volume":"92","author":"Berends","year":"2001","journal-title":"Int J Cancer"},{"key":"R39-16-20210131","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0165-4608(98)00252-0","article-title":". Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members.","volume":"112","author":"Ichikawa","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"R40-16-20210131","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/his.12028","article-title":"Hereditary gynaecological malignancies: advances in screening and treatment.","volume":"62","author":"Folkins","year":"2013","journal-title":"Histopathology"},{"key":"R41-16-20210131","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PAS.0b013e318197a046","article-title":". Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.","volume":"33","author":"Garg","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R42-16-20210131","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jcp.2009.064949","article-title":"Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.","volume":"62","author":"Garg","year":"2009","journal-title":"J Clin Pathol"},{"key":"R43-16-20210131","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0002-9440(10)63605-X","article-title":". Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.","volume":"163","author":"Tsuchiya","year":"2003","journal-title":"Am J Pathol"},{"key":"R44-16-20210131","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/his.12286","article-title":". Immunohistochemical characterization of prototypical endometrial clear cell carcinomadiagnostic utility of HNF-1beta and oestrogen receptor.","volume":"64","author":"Hoang","year":"2014","journal-title":"Histopathology"},{"key":"R45-16-20210131","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/PAI.0b013e31824973d1","article-title":"Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma.","volume":"20","author":"Fadare","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R46-16-20210131","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/modpathol.3800492","article-title":"Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary.","volume":"19","author":"Kato","year":"2006","journal-title":"Mod Pathol"},{"key":"R47-16-20210131","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.3390\/ijms14035367","article-title":". Endometriosis-associated ovarian cancer: a review of pathogenesis.","volume":"14","author":"Worley","year":"2013","journal-title":"Int J Mol Sci"},{"key":"R48-16-20210131","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/1097-0142(20000615)88:12<2774::AID-CNCR16>3.0.CO;2-I","article-title":". Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.","volume":"88","author":"Wang","year":"2000","journal-title":"Cancer"},{"key":"R49-16-20210131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.pai.0000162003.43334.c7","article-title":"GLUT-1 is preferentially expressed in atypical endometrial hyperplasia and endometrial adenocarcinoma.","volume":"14","author":"Ashton-Sager","year":"2006","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R50-16-20210131","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s12253-012-9500-5","article-title":". Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.","volume":"18","author":"Krzeslak","year":"2012","journal-title":"Pathol Oncol Res"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:44:54Z","timestamp":1620967494000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201508000-00016"}},"subtitle":["An Immunohistochemical and Molecular Study of 21 Cases"],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000428","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}